Advertisement

Is peanut sensitisation screening cost effective in high-risk infants?

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Reference

    1. Greenhawt M, et al. Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction. JAMA Network Open : 20 Dec 2019. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2019.18041

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Is peanut sensitisation screening cost effective in high-risk infants?. PharmacoEcon Outcomes News 844, 22 (2020) doi:10.1007/s40274-020-6485-2

    Download citation